Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Goodwill: 2016-2024

Historic Goodwill for Tg Therapeutics (TGTX) over the last 8 years, with Mar 2024 value amounting to $799,000.

  • Tg Therapeutics' Goodwill changed negligibly% to $799,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $799,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $799,000 for FY2023, which is negligibly% changed negligibly from last year.
  • Per Tg Therapeutics' latest filing, its Goodwill stood at $799,000 for Q1 2024, which was down 0.00% from $799,000 recorded in Q4 2023.
  • Tg Therapeutics' Goodwill's 5-year high stood at $799,000 during Q1 2020, with a 5-year trough of $799,000 in Q1 2020.
  • Its 3-year average for Goodwill is $799,000, with a median of $799,000 in 2024.